Wet AMD 3 Symposium

Related

• 

  Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study

  Priyatham (Prithu) S Mettu, MD

  Updates from the Field

  2019

• 

  PRN cycles of three monthly anti-VEGF injections in neovascular AMD: 12 and 24 months results.

  Touka Banaee, MD

  On Demand Cases, Courses, and Papers

  2019

• 

  Wet AMD

  Jared Watson

  Paul Yates, MD, PhD

  Retina Image Bank: Images of the Week

  2015